We operate state-of-the-art manufacturing plants in Gaindakot-10, a pollution-free zone. All our facilities comply with both National GMP and WHO-GMP standards.
The Production Department operates in strict compliance with established quality and regulatory standards, ensuring that all products consistently meet global benchmarks. Designed with efficient spatial configurations and equipped with state-of-the-art technology, the facility supports high-throughput manufacturing across multiple dosage forms to address evolving market needs.
The department maintains close integration with the R&D division to enable the seamless transfer of technology and the commercialization of innovative, safe, and efficacious pharmaceutical products. A team of highly skilled professionals, supported by robust quality systems and a culture of continuous process improvement, drives operational excellence and manufacturing efficiency.
The production facility is equipped to manufacture a diverse range of pharmaceutical dosage forms, including Tablets, Capsules, Oral Liquids (Syrups/Suspensions), and Topical Preparations (Ointments/Creams).
State-of-the-art, high-efficiency manufacturing equipment enables scalable production while ensuring consistency, precision, and minimal product variability across all dosage forms.
All operations are conducted in full adherence to current Good Manufacturing Practices (cGMP) and WHO GMP guidelines, ensuring regulatory compliance and the highest standards of product quality, safety, and efficacy.
A dedicated, standalone facility established in 2063 B.S., the Penicillin Unit is designed to handle β-lactam antibiotics with complete containment and compliance.
Dosage Forms Handled:
Facility Highlights:
A purpose-built, dedicated facility commissioned in 2072 B.S., the Cephalosporin Unit is engineered to handle cephalosporin-class antibiotics with the highest standards of containment and compliance.
Dosage Forms Manufactured:
Facility Features:
Commissioned in 2067 B.S., the Sterile Unit is a dedicated facility designed specifically for the aseptic manufacturing of sterile pharmaceutical products, ensuring the highest levels of product safety and compliance.
Dosage Forms Produced:
Facility Highlights:
The Non-Penicillin Section at TIME Pharmaceuticals Limited is a fully segregated, WHO-GMP–compliant facility designed to ensure zero cross-contamination with Penicillin products. Equipped with dedicated HVAC systems, modern production lines, and validated cleaning protocols, we manufacture tablets, capsules, ointments, creams, and oral liquids across a wide range of therapeutic areas, including cardiovascular, antidiabetic, CNS, gastrointestinal, dermatology, and nutrition. Every batch undergoes stringent in-process controls and quality testing in our advanced QC laboratory. With dedicated staff, specialized equipment, and a robust documentation system, we consistently meet WHO-GMP standards, delivering safe, effective, and high-quality medicines for both domestic and international markets.